Compile Data Set for Download or QSAR
Report error Found 46 Enz. Inhib. hit(s) with all data for entry = 13315
TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM65454(Lenalidomide | US9694015, 6.1 | 191732-72-6 | Revl...)
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM65456(pomalidomide | US9694015, 6.2 | 19171-19-8 | 4-ami...)
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777355(US20250313547, Example 9 | US12441708, Example 9)
Affinity DataKd:  5.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777348(US20250313547, Example 2 | US12441708, Example 2)
Affinity DataKd:  5.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777347(US20250313547, Example 1 | US12441708, Example 1)
Affinity DataKd:  5.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777378(US20250313547, Example 32 | US12441708, Example 32)
Affinity DataKd:  5.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777376(US20250313547, Example 30 | US12441708, Example 30)
Affinity DataKd:  5.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777375(US20250313547, Example 29 | US12441708, Example 29)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777390(US20250313547, Example 44 | US12441708, Example 44)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777374(US20250313547, Example 28 | US12441708, Example 28)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777389(US20250313547, Example 43 | US12441708, Example 43)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777386(US20250313547, Example 40 | US12441708, Example 40)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777369(US20250313547, Example 23 | US12441708, Example 23)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777351(US20250313547, Example 5 | US12441708, Example 5)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777350(US20250313547, Example 4 | US12441708, Example 4)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777349(US20250313547, Example 3 | US12441708, Example 3)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777380(US20250313547, Example 34 | US12441708, Example 34)
Affinity DataKd:  5.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM76986(3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-pipe...)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM50146598(CHEMBL3764647 | US20250313547, Example 12 | US1244...)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777357(US20250313547, Example 11 | US12441708, Example 11)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777356(US20250313547, Example 10 | US12441708, Example 10)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777354(US20250313547, Example 8 | US12441708, Example 8)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777353(US20250313547, Example 7 | US12441708, Example 7)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777352(US20250313547, Example 6 | US12441708, Example 6)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777367(US20250313547, Example 21 | US12441708, Example 21)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777366(US20250313547, Example 20 | US12441708, Example 20)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777365(US20250313547, Example 19 | US12441708, Example 19)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777364(US20250313547, Example 18 | US12441708, Example 18)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM511657(US11059801, Compound D-24 | US20250313547, Example...)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM50111214(2-[2-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-eth...)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777361(US20250313547, Example 15 | US12441708, Example 15)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777360(US20250313547, Example 14 | US12441708, Example 14)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777388(US20250313547, Example 42 | US12441708, Example 42)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777387(US20250313547, Example 41 | US12441708, Example 41)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777385(US20250313547, Example 39 | US12441708, Example 39)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777384(US20250313547, Example 38 | US12441708, Example 38)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777373(US20250313547, Example 27 | US12441708, Example 27)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM50111220(2-(2,4-Dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-is...)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777371(US20250313547, Example 25 | US12441708, Example 25)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777370(US20250313547, Example 24 | US12441708, Example 24)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777368(US20250313547, Example 22 | US12441708, Example 22)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777383(US20250313547, Example 37 | US12441708, Example 37)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777382(US20250313547, Example 36 | US12441708, Example 36)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777381(US20250313547, Example 35 | US12441708, Example 35)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777379(US20250313547, Example 33 | US12441708, Example 33)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent

TargetProtein cereblon(Human)
Arvinas Operations

US Patent
LigandPNGBDBM777377(US20250313547, Example 31 | US12441708, Example 31)
Affinity DataKd: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/26/2026
Entry Details US Patent